Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Eclinicalmedicine
|
July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
Taufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
American Journal of Nephrology
|
April 24, 2022
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)
Dhananjai Agrawal, Deepak Varade, Hardik Shah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)
Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 4, 2020
Reply to Agrawal and Kumar
Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Pharmacokinetics
|
May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Kevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
The Lancet. Infectious Diseases
|
March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
Bridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
Metabolism Open
|
April 9, 2026
Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial
Prabhat Kumar Sharma, Sagar Vivek Redkar, Abhishek Madhav Karmalkar, et al.
Metabolism Open
|
June 22, 2026
Corrigendum to "Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial" [Metabol Open 30 (2026) 100460]
Prabhat Kumar Sharma, Sagar Vivek Redkar, Abhishek Madhav Karmalkar, et al.
Metabolism Open
|
June 8, 2026
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Prabhat Kumar Sharma, V Viswaprasad, Animesh Choudhary, et al.
Ophthalmology and Therapy
|
January 23, 2026
A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea<sup>®</sup> in Patients with Wet Age-Related Macular Degeneration
Mudit Bansal, Punit Singh, Ruchi K Mehta, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Eclinicalmedicine
|
July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
Taufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
American Journal of Nephrology
|
April 24, 2022
Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND)
Dhananjai Agrawal, Deepak Varade, Hardik Shah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)
Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 4, 2020
Reply to Agrawal and Kumar
Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
Clinical Pharmacokinetics
|
May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Kevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
The Lancet. Infectious Diseases
|
March 5, 2022
Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
Bridget E Barber, Melissa Fernandez, Hardik Babubhai Patel, et al.
Metabolism Open
|
April 9, 2026
Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in indian adults with obesity: A phase III randomized non-inferiority trial
Prabhat Kumar Sharma, Sagar Vivek Redkar, Abhishek Madhav Karmalkar, et al.
Metabolism Open
|
June 22, 2026
Corrigendum to "Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial" [Metabol Open 30 (2026) 100460]
Prabhat Kumar Sharma, Sagar Vivek Redkar, Abhishek Madhav Karmalkar, et al.
Metabolism Open
|
June 8, 2026
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Prabhat Kumar Sharma, V Viswaprasad, Animesh Choudhary, et al.
Ophthalmology and Therapy
|
January 23, 2026
A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea<sup>®</sup> in Patients with Wet Age-Related Macular Degeneration
Mudit Bansal, Punit Singh, Ruchi K Mehta, et al.
Page
of 4